Category Archives: ALS Newsroom

Centaur Trial (AMX0035): Longterm Survival Data

MOFF attended the NEALS webinar hosted by Dr. Sabrina Paganoni and Dr. Merit Cudkowicz on

Prop 14 (CA)

What’s all the buzz about Proposition 14? Why is the scientific community encouraging everyone to vote

Novus Acquisition of Anelixis

The Martha Olson-Fernandez Foundation (MOFF) was very excited to hear that Novus Therapeutics had finalized

CRISPR and ALS

Brief Overview CRISPR is a highly specific and efficient genome editing technology. CRISPR facilitates the

ALS/MND International Alliance Scientific Advisory Council Meeting

MOFF attended the ALS/MND International Alliance Scientific Advisory Council Meeting on June 17th (at 4

The Political Front: National ALS Advocacy Conference

The National ALS Advocacy Conference (May 26, 2020 – June 3, 2020) The National ALS

ALS Biomarker Panel at the Society for Brain Mapping and Therapeutics Conference

15–17 March 2019 SBMT 16th Annual Congress Los Angeles Convention Center in LA FLYER The

2019 California ALS Research Summit

Day 1 Takeaways: 1. Whole genome sequencing (WGS) analysis projects are being undertaken by the